09.24.18 Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) in Non-Small Cell Lung Cancer
09.05.18 Syndax to Present at the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer
